AMR-103

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAMR-103
Drug Alias NameAMR-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors agonists
TargetsDopamine receptors
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmarin Corporation Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmarin Corporation Plc
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A